Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
BioRestorative Therapies ( (BRTX) ) has shared an announcement.
BioRestorative Therapies, a regenerative medicine company, announced promising developments in their stem cell-based therapies, reporting financial progress and a provisional license for processing non-autologous donor tissue. The company shared advancements in their BRTX-100 clinical trials for lumbar disc disease and their ThermoStem program aimed at metabolic disorders, while also noting increased revenue from BioCosmeceutical products. With no outstanding debt and a strong financial position, BioRestorative is poised for continued growth in the innovative stem cell therapy market.
For an in-depth examination of BRTX stock, go to TipRanks’ Stock Analysis page.
